Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-2330.57%EBITDA Margin
VS
Market
Sector
Industry
History
$ 3.15Close
$ 2.35 - $ 6.36 52-Week Range
Ticker Information
Ticker
OBIOCompany Name
ORCHESTRA BIOMED HOLDINGS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQORCHESTRA BIOMED HOLDINGS INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
OBIO - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -68.61M | -2330.57% | $ 2.94M |
| 3/31/2025 | $ -65.25M | -2260.98% | $ 2.89M |
| 12/31/2024 | $ -60.06M | -2276.8% | $ 2.64M |
| 9/30/2024 | $ -53.99M | -2039.52% | $ 2.65M |
| 6/30/2024 | $ -52.92M | -2545.31% | $ 2.08M |
| 3/31/2024 | $ -49.94M | -2253.47% | $ 2.22M |
| 12/31/2023 | $ -48.2M | -1746.41% | $ 2.76M |
| 9/30/2023 | $ -48.35M | -1342.74% | $ 3.6M |
| 9/30/2022 | $ -1.95M | 0% | $ 0 |
| 6/30/2022 | $ -1.35M | 0% | $ 0 |
Key Performance Insights, Last 5 Years
- ORCHESTRA BIOMED HOLDINGS INC's latest trailing twelve months (TTM) EBITDA % stands at 0%.
- Over the past 5 years, ORCHESTRA BIOMED HOLDINGS INC's average EBITDA % has been -2099.48%.
- The median EBITDA % for ORCHESTRA BIOMED HOLDINGS INC during this period was -2257.23%
- ORCHESTRA BIOMED HOLDINGS INC reached its highest EBITDA % over the past 5 years at -1342.74%.
- The lowest EBITDA % recorded by ORCHESTRA BIOMED HOLDINGS INC in the same timeframe -2545.31%
ORCHESTRA BIOMED HOLDINGS INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for ORCHESTRA BIOMED HOLDINGS INC is calculated as follows: EBITDA [ $ -173.54K ] / Revenues [ $ 0 ]
(=) EBITDA % [ 0% ] OBIO - EBITDA Margin, Last 5 years
-2545.31%
Minimum
Jun 30, 2024
-1342.74%
Maximum
Sep 30, 2023
-2099.48%
Average
-2257.23%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -74.33% |
| max | 97.24% |
| average | 16.2% |
| median | 14.74% |
| std | 26.73% |